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Editorial
European Federation of Clinical Chemistry and 
Laboratory Medicine (EFLM) Working group for 
preanalytical phase (WG-PRE) has recently 
launched a series of conferences on preanalytical 
phase. First such meeting was held in Parma (Italy) 
in the spring of 2011 and the second one took 
place in Zagreb (Croatia) during 1-2 March 2013. 
The Zagreb audience had the opportunity to en-
joy a focused and challenging scientific program 
as well as to participate actively in interactive e-
voting sessions.
Speakers of the conference have kindly accepted 
the invitation to submit their review articles cover-
ing topics presented during the meeting. This 
Journal issue comprises a number of high quality 
review articles providing an updated overview of 
the current evidence on the various preanalytical 
issues. The first article in this series is presented by 
prof. Walter G. Guder who has prepared a histori-
cal overview of the milestones in the development 
of the key concepts in the field of preanalytical 
phase (1). Bowen and Remaley in their article pro-
vide an excellent update on the most important 
blood collection tube additives and their compo-
nents which may affect laboratory test results (2). 
De Carli and her colleagues have compiled the ex-
isting evidence of healthcare workers risk of sharps 
injuries and subsequent infections and review re-
spective prevention strategies (3). Several subse-
quent articles are dedicated to some preanalytical 
sources of interferences such as lipemia (4), physi-
cal activity (5) and medical contrast media (6). De-
langhe and Speeckaert have reviewed current pre-
analytical problems and requirements for the most 
common urinary analytes, with a special highlight 
of the importance of the preanalytical phase in 
urine toxicology and metabolomics (7). Last, but 
not the least, this article series also covers the recent 
advances in the harmonization of preanalytical 
quality indicators (8) and External Quality Assess-
ment Schemes for the pre-analytical phase (9).
We hope that this series shall contribute to the 
better understanding and recognition of various 
important preanalytical phase variables. As this 
body of evidence grows, we will keep you updated 
by providing high quality reviews and original re-
search addressing the current and future preana-
lytical challenges. 
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